Cohort1: placebo_Single dose
|
Administration route |
subcutaneous injection |
Dosage |
placebo, Single dose, on Day 1 of single-dose treatment period |
Age |
Adult, Older_Adult |
|
Cohort2: Pelacarsen_dose level1_single-dose treatment period
|
Administration route |
subcutaneous injection |
Dosage |
Pelacarsen, 20 mg, Single dose, on Day 1 of single-dose treatment period |
Age |
Adult, Older_Adult |
|
Cohort3: Pelacarsen_dose level2_single-dose treatment period
|
Administration route |
subcutaneous injection |
Dosage |
Pelacarsen, 40 mg, Single dose, on Day 1 of single-dose treatment period |
Age |
Adult, Older_Adult |
|
Cohort4: Pelacarsen_dose level3_single-dose treatment period
|
Administration route |
subcutaneous injection |
Dosage |
Pelacarsen, 80 mg, Single dose, on Day 1 of single-dose treatment period |
Age |
Adult, Older_Adult |
|
Cohort5: placebo_Multiple doses
|
Administration route |
subcutaneous injection |
Dosage |
placebo, Multiple doses, every 4 weeks, on Days 1, 29, 57 and 85 of multiple-dose treatment period |
Age |
Adult, Older_Adult |
|
Cohort6: Pelacarsen_dose level3_multiple-dose treatment period
|
Administration route |
subcutaneous injection |
Dosage |
Pelacarsen, 80 mg, every 4 weeks, on Days 1, 29, 57 and 85 of multiple-dose treatment period |
Age |
Adult, Older_Adult |
|